La vendita allo scoperto per Mesa Royalty dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Mesa Royalty. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Mesa Royalty (NYSE:MTR) Azioni, Report sulle vendite allo scoperto

Mesa Royalty

Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.

Mesa Royalty Trust

Metro Inc

Metro Bank Holdings PLC

Metaterra Corp

Meter Governance

MTR Corp Ltd

Matricelf Ltd

Materion Corp

METRO ONE DEV INC NEW by Metro One Development, Inc.

METAL ARTS CO INC by Metal Arts Company, Inc.

Metal Arts Co Inc

Matrix Service Co

Monterey Innovation Acquisition Corp

Monterey Innovation Acquisition Corp Units (1 Ord Share & 1 War)

Monterey Innovation Acquisition Corp Warrants (30/09/2026)

Mesa Royalty Trust (the "Trust") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>) announced today that there will be no distribution paid for the month of August 2024 to holders of record on August 30, 2024, as costs, charges and expenses attributable to the Trust's royalty properties, and applicable reserves, exceeded the revenue received from the sale of oil, natural gas and other hydrocarbons produced from such properties, as reported by the working interest owners.

News

Dividends

Mesa Royalty Trust Announces There Will Be No Distribution Paid For The Month Of August 2024 To Holders Of Record On August 30, 2024

Friday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a monthly dividend of 1.71 cents per share. On Monday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 1.71 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Monday. Shareholders who own MTR as of the end of Friday's session are eligible to receive the 1.71 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 31, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on Mesa Royalty <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Mesa Royalty: Dividend Insights

WIIM

CIVI

LBRT

PFIE

PTEN

STNG

TRGP

VTLE

WFRD

Shares of energy stocks are trading lower amid a drop in oil prices.

Thursday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a monthly dividend of 5.8 cents per share. On Friday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 5.8 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own MTR as of the end of Thursday's session are eligible to receive the 5.8 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on October 31, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on Mesa Royalty's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

CTRA

EQNR

FANG

MTDR

Shares of oil and energy companies are trading lower after Russian Deputy Prime Minister Novak said he expects no new steps from OPEC+ at its Jun. 4 meeting.

BANL

NESR

Shares of companies in the broader energy space are trading lower amid demand uncertainty. Weak Q1 earnings from UPS and Chinese economic recovery concerns may be clouding the demand outlook for oil.

Wednesday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>). 
<h3>What's Happening</h3>
The company announced on Tuesday that it would pay shareholders a monthly dividend of 11.18 cents per share. On Thursday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 11.18 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Thursday. Shareholders who own MTR as of the end of Wednesday's session are eligible to receive the 11.18 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on April 28, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on Mesa Royalty <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Friday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 15.81 cents per share. On Monday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 15.81 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Monday. Shareholders who own MTR as of the end of Friday's session are eligible to receive the 15.81 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on April 28, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Friday Is Your Last Chance To Buy Mesa Royalty Before The Dividend Payout

ACDC

AMPY

CEIX

CSAN

GPRK

HNRG

KLXE

NINE

SBOW

TUSK

VNOM

WTTR

Shares of oil & gas companies are trading lower as oil prices fall amid macroeconomic uncertainty.

Wednesday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>). 
<h3>What's Happening</h3>
The company announced on Tuesday that it would pay shareholders a monthly dividend of 20.12 cents per share. On Thursday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 20.12 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Thursday. Shareholders who own MTR as of the end of Wednesday's session are eligible to receive the 20.12 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 31, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Mesa Royalty's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 18.5 cents per share. On Tuesday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 18.5 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own MTR as of the end of Monday's session are eligible to receive the 18.5 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 31, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on Mesa Royalty <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Thursday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a monthly dividend of 18.18 cents per share. On Friday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 18.18 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own MTR as of the end of Thursday's session are eligible to receive the 18.18 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 31, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on Mesa Royalty's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Mesa Royalty's Ex-Dividend Date Is Friday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>). 
<h3>What's Happening</h3>
The company announced on Tuesday that it would pay shareholders a monthly dividend of 12.45 cents per share. On Thursday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 12.45 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Thursday. Shareholders who own MTR as of the end of Wednesday's session are eligible to receive the 12.45 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on October 31, 2022. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on Mesa Royalty's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

CEQP

CRGY

DINO

DMLP

ENLC

ETRN

EURN

EZFL

GLNG

MPLX

PAGP

PARR

PDCE

Shares of several oil & gas companies are trading lower amid strength in the dollar and increased fears of an economic slowdown as investors continue to assess Wednesday's Fed commentary and 75 bps rate hike.

ALTO

MARPS

ROCC

TALO

VTNR

Shares of energy companies are trading lower as the sector pulls back from recent gains amid raised concerns of aggressive interest rates hikes, which could pressure oil demand.

Wednesday marks the last chance for investors to receive the next dividend payout from Mesa Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTR#NYSE">MTR</a>).
<h3>What&#39;s Happening</h3>
The company announced on Tuesday that it would pay shareholders a monthly dividend of 9.55 cents per share. On Thursday, Mesa Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 9.55 cents lower than it would have opened on any other day.
In order to be eligible to receive a company&#39;s dividend, shareholders must own the stock prior to the ex-dividend date&mdash;in this case, Thursday. Shareholders who own MTR as of the end of Wednesday&#39;s session are eligible to receive the 9.55 cents dividend payout for every share that they own.
According to the company, this dividend will be paid out to shareholders on October 31, 2022. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way.
To stay up-to-date with the companies that are announcing their dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

<h3>Gainers</h3>
<ul>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) shares jumped 59.9% to close at $2.35 on Wednesday. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year growth in revenue for the first quarter.</li>
<li>Stronghold Digital Mining, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sdig#NASDAQ">SDIG</a>) climbed 50% to close at $3.21 following continuation of crypto rally.</li>
<li>ToughBuilt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tblt#NASDAQ">TBLT</a>) jumped 36% to close at $4.19 after climbing around 15% on Tuesday. ToughBuilt Industries recently announced its Q2 gross sales through Amazon were $3.56 million, representing a 20% year-over-year increase.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) rose 28.7% to close at $11.84 after the company reported fourth-quarter sales growth of 166% year-over-year to $20.3 million, beating the consensus of $20.02 million. Separately, the company announced that it has received $12.8 million in orders from its lead silicon carbide test and burn-in customer for multiple FOX-XP&trade; systems, a FOX&trade; high volume production WaferPak Aligner, and a small number of FOX WaferPak full wafer contactors.</li>
<li>Waitr Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wtrh#NASDAQ">WTRH</a>) gained 28.1% to close at $0.3150.</li>
<li>Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) rose 27.6% to settle at $1.85.</li>
<li>AMCON Distributing Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dit#NYSE">DIT</a>) surged 26.4% to close at $243.99. Amcon Distributing recently posted Q3 EPS of $10.27.</li>
<li>Rhythm Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rytm#NASDAQ">RYTM</a>) jumped 24.9% to close at $13.21 after the French National Agency for Medicines and Health Products Safety and Haute Autorit&eacute; de sant&eacute; granted pre-marketing authorization AP1 for IMCIVREE for patients with genetically-confirmed Bardet-Biedl syndrome for the treatment of obesity and the control of hunger.</li>
<li>Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhat#NASDAQ">BHAT</a>) gained 24.9% to settle at $3.06.</li>
<li>The OLB Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olb#NASDAQ">OLB</a>) jumped 23.9% to settle at $1.45.</li>
<li>Calithera Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cala#NASDAQ">CALA</a>) surged 23.3% to close at $3.44.</li>
<li>Allakos Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allk#NASDAQ">ALLK</a>) gained 21.7% to close at $4.09.</li>
<li>Acutus Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afib#NASDAQ">AFIB</a>) jumped 20.9% to settle at $1.39.</li>
<li>Cellectar Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clrb#NASDAQ">CLRB</a>) gained 20.7% to close at $0.5913.</li>
<li>LM Funding America, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmfa#NASDAQ">LMFA</a>) surged 20.6% to settle at $1.11. LMF Acquisition Opportunities, Inc&rsquo;s combination partner SeaStar Medical submitted Humanitarian Device Exemption Application to the FDA for use of selective cytopheretic device in children with acute kidney injury.</li>
<li>HEXO Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hexo#NASDAQ">HEXO</a>) gained 20.5% to settle at $0.2338. Shares of cannabis companies traded higher in anticipation of a Senate marijuana meeting.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) rose 19.9% to close at $0.6850. Dave is one of the most-discussed stocks in Benzinga Pro&#39;s lounge chat Wednesday morning.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) gained 19.8% to settle at $27.38.</li>
<li>Kaleyra, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/klr#NYSE">KLR</a>) jumped 19.7% to close at $2.31.</li>
<li>Arrival (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arvl#NASDAQ">ARVL</a>) gained 19.4% to close at $1.85. Arrival recently proposed a business reorganisation.</li>
<li>Applied Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) shares rose 17.5% to close at $2.49. Applied Blockchain shares jumped 100% on Tuesday after the company raised its Q4 revenue guidance. Also, the company announced a 5-year hosting contract with Marathon Digital.</li>
<li>Senti Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snti#NASDAQ">SNTI</a>) gained 17.5% to close at $2.08.</li>
<li>New Relic, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newr#NYSE">NEWR</a>) rose 17.5% to close at $61.55.</li>
<li>Bright Minds Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drug#NASDAQ">DRUG</a>) rose 17.5% to close at $1.01.</li>
<li>Capstone Green Energy Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgrn#NASDAQ">CGRN</a>) gained 17.3% to close at $1.83.</li>
<li>Bright Scholar Education Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bedu#NYSE">BEDU</a>) gained 16.9% to close at $0.9177. Bright Scholar will hold 2022 Annual General Meeting on August 22, 2022.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) rose 16.9% to close at $3.05. Canopy Growth closed its exchange transaction of certain 4.25% unsecured notes due 2023 in order to reduce its debt obligations by around CA$263 million.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) gained 14.3% to close at $75.27 amid an increase in the price of Bitcoin and Ethereum.</li>
<li>Exela Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xela#NASDAQ">XELA</a>) jumped 14.3% to close at $0.1515.</li>
<li>Unity Software Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/u#NYSE">U</a>) gained 13.7% to close at $40.52. Shares of technology and software companies traded higher amid a drop in yields.</li>
<li>Shopify Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shop#NYSE">SHOP</a>) jumped 12% to close at $15.51. Shares of technology and software companies traded higher amid a drop in yields.</li>
<li>Inovio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ino#NASDAQ">INO</a>) gained 11% to close at $2.23. Inovio Pharmaceuticals implemented a corporate reorganization designed to extend its cash runway and focus on key clinical programs.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) gained 9.6% to settle at $15.51.</li>
<li>Leafly Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lfly#NASDAQ">LFLY</a>) gained 9.4% to close at $5.10.</li>
<li>Precigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgen#NASDAQ">PGEN</a>) rose 9.1% to settle at $1.91.</li>
<li>Datadog, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ddog#NASDAQ">DDOG</a>) rose 8.5% to settle at $100.88 after Bernstein initiated coverage on the stock with an Outperform rating and a $172 price target.</li>
<li>Ideanomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idex#NASDAQ">IDEX</a>) gained 7.7% to close at $0.7650. Ideanomics unit Solectrac recently announced a partnership with Nolan Manufacturing to produce Solectrac&#39;s e25 electric tractors with additional models slated for future production.</li>
<li>Netflix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nflx#NASDAQ">NFLX</a>) gained 7.4% to close at $216.44. Netflix posted better-than-expected earnings for its second quarter. The company ended the second quarter with 220.67 million subscribers, down from a reported 221.64 million in the first quarter.</li>
<li>Cloudflare, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/net#NYSE">NET</a>) gained 7% to close at $53.00. Shares of technology and software companies traded higher amid a drop in yields.</li>
<li>SCYNEXIS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scyx#NASDAQ">SCYX</a>) gained 6.1% to close at $2.25. Scynexis announced the presentation of positive outcomes from the CANDLE 304s nested sub-study of ibrexafungerp in recurrent vulvovaginal candidiasis (RVVC) who failed fluconazole treatment.</li>
<li>Amazon.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) rose 3.9% to close at $122.77. Jefferies maintained Amazon.com with a Buy and lowered the price target from $163 to $150.</li>
<li>Omnicom Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/omc#NYSE">OMC</a>) rose 3.9% to settle at $70.06 as the company posted stronger-than-expected results for its second quarter on Tuesday.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Vascular Biogenics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vblt#NASDAQ">VBLT</a>) shares tumbled 79.3% to close at $0.4250 on Wednesday after the company announced the data from its Phase 3 OVAL trial of ofra-vec did not meet the primary endpoints of achieving a statistically significant improvement.</li>
<li>JE Cleantech Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jcse#NASDAQ">JCSE</a>) dipped 75.2% to settle at $3.00.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) fell 46.7% to close at $0.98 after the company announced topline results for its Onward Phase 3 trial for AD04 in patients with Alcohol Use Disorder.</li>
<li>Tuesday Morning Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tuem#NASDAQ">TUEM</a>) dropped 30% to close at $0.1987. BWS Financial recently downgraded Tuesday Morning from Buy to Neutral and announced a $0.5 price target.</li>
<li>FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) fell 24.1% to close at $9.88. A SPAC merger announced between FaZe Clan and B. Riley Principal 150 Merger Corp in October has been completed.</li>
<li>ArcLight Clean Transition Corp. II (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/actd#NASDAQ">ACTD</a>) dropped 23% to close at $7.82.</li>
<li>Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) fell 22.8% to close at $0.8807.</li>
<li>Belite Bio, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blte#NASDAQ">BLTE</a>) fell 22.1% to close at $34.01. Belite Bio submitted an Investigational New Drug Application to the FDA to support Phase 3 development of LBS-008 for Stargardt Disease (STGD1), a rare genetic eye disease.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crkn#NASDAQ">CRKN</a>) fell 19.4% to close at $4.53 after the company priced its common stock offering of 1.25 million shares at $0.80 per share.</li>
<li>OptimizeRx Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oprx#NASDAQ">OPRX</a>) fell 17.7% to close at $24.64. B. Riley Securities maintained OptimizeRx with a Buy and lowered the price target from $71 to $56.</li>
<li>Inozyme Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inzy#NASDAQ">INZY</a>) fell 16.9% to close at $4.53. Inozyme Pharma announced preliminary biomarker, safety, and pharmacokinetic (PK) data from the first three subjects in the Phase 1 portion of its ongoing Phase 1/2 trial of INZ-701 in ABCC6 Deficiency, which presents as pseudoxanthoma elasticum (PXE) in older individuals.</li>
<li>Mesa Royalty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtr#NYSE">MTR</a>) fell 16.9% to close at $12.35.</li>
<li>AMTD Digital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hkd#NYSE">HKD</a>) shares dropped 16.8% to close at $20.70. AMTD Digital shares dropped over 10% on Tuesday on continued volatility following the company&#39;s recent IPO.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffie#NASDAQ">FFIE</a>) fell 16.3% to close at $4.64.</li>
<li>Healthcare Services Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) fell 16.2% to close at $15.55 after the company posted second-quarter FY22 revenue growth of 6.7% year-over-year to $424.9 million, missing the consensus of $426.72 million.</li>
<li>Schmitt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smit#NASDAQ">SMIT</a>) dropped 16% to settle at $3.94. Schmitt Industries entered into term sheet with Proton Green and announced spin-off of its Ample Hills Business.</li>
<li>ITHAX Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mond#NASDAQ">MOND</a>) fell 12.4% to close at $7.99.</li>
<li>Forestar Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/for#NYSE">FOR</a>) fell 10.3% to close at $14.21 after the company reported worse-than-expected Q3 EPS and sales results and issued FY22 revenue guidance below estimates.</li>
<li>Baker Hughes Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bkr#NYSE">BKR</a>) fell 8.3% to close at $25.89 after the company reported worse-than-expected Q2 EPS and sales results.</li>
<li>Biogen Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biib#NASDAQ">BIIB</a>) dropped 5.8% to close at $207.49. Biogen disclosed in its second-quarter earnings report that it recorded $900 million related to a settlement agreement to resolve previously disclosed &quot;qui tam&quot; litigation related to its conduct before 2015.</li>
</ul>

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACTD

ADIL

AEHR

AFIB

ALLK

AMZN

APLD

ARVL

AVGR

BEDU

BHAT

BIIB

BLTE

CALA

CGRN

CLRB

COIN

CRKN

CVNA

DAVE

DDOG

DRCT

DRUG

FAZE

FFIE

HCSG

HEXO

IDEX

INZY

JCSE

LFLY

LMFA

MOND

NEWR

NFLX

OPRX

PGEN

REVB

RYTM

SCYX

SDIG

SHOP

SMIT

SNAP

SNTI

TBLT

TUEM

VBLT

WTRH

XELA

Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year growth in revenue for the first quarter.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) shares jumped 73.7% to $4.6890 on continued volatility after the company completed its SPAC merger agreement last month. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.</li>
<li>Stronghold Digital Mining, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sdig#NASDAQ">SDIG</a>) gained 48.8% to $3.1850 following continuation of crypto rally.</li>
<li>Bright Scholar Education Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bedu#NYSE">BEDU</a>) surged 33.7% to $1.05. Bright Scholar will hold 2022 Annual General Meeting on August 22, 2022.</li>
<li>Applied Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) shares gained 25.5% to $2.66. Applied Blockchain shares jumped 100% on Tuesday after the company raised its Q4 revenue guidance. Also, the company announced a 5-year hosting contract with Marathon Digital.</li>
<li>Allakos Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allk#NASDAQ">ALLK</a>) jumped 23.8% to $4.16.</li>
<li>Rhythm Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rytm#NASDAQ">RYTM</a>) surged 22.6% to $12.98 after the French National Agency for Medicines and Health Products Safety and Haute Autorit&eacute; de sant&eacute; granted pre-marketing authorization AP1 for IMCIVREE for patients with genetically-confirmed Bardet-Biedl syndrome for the treatment of obesity and the control of hunger.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) gained 21.6% to $0.6952. Dave is one of the most-discussed stocks in Benzinga Pro&#39;s lounge chat Wednesday morning.</li>
<li>Leafly Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lfly#NASDAQ">LFLY</a>) jumped 17.1% to $5.45.</li>
<li>ToughBuilt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tblt#NASDAQ">TBLT</a>) gained 16.2% to $3.58 after climbing around 15% on Tuesday. ToughBuilt Industries recently announced its Q2 gross sales through Amazon were $3.56 million, representing a 20% year-over-year increase.</li>
<li>Inovio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ino#NASDAQ">INO</a>) jumped 15.2% to $2.3155. Inovio Pharmaceuticals implemented a corporate reorganization designed to extend its cash runway and focus on key clinical programs.</li>
<li>SCYNEXIS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scyx#NASDAQ">SCYX</a>) jumped 15% to $2.4373. Scynexis announced the presentation of positive outcomes from the CANDLE 304s nested sub-study of ibrexafungerp in recurrent vulvovaginal candidiasis (RVVC) who failed fluconazole treatment.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) gained 15% to $3.00. Canopy Growth closed its exchange transaction of certain 4.25% unsecured notes due 2023 in order to reduce its debt obligations by around CA$263 million.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) jumped 13.7% to $74.88 amid an increase in the price of Bitcoin and Ethereum.</li>
<li>Capstone Green Energy Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgrn#NASDAQ">CGRN</a>) rose 13.5% to $1.77.</li>
<li>Cloudflare, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/net#NYSE">NET</a>) jumped 12.7% to $55.83. Shares of technology and software companies traded higher amid a drop in yields.</li>
<li>Precigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgen#NASDAQ">PGEN</a>) gained 12.3% to $1.9650.</li>
<li>Unity Software Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/u#NYSE">U</a>) jumped 11.7% to $39.83. Shares of technology and software companies traded higher amid a drop in yields.</li>
<li>Greenlane Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnln#NASDAQ">GNLN</a>) gained 11.5% to $0.2167. Greenlane said it has sold its stake in VIBES Holdings LLC for $5.3 million in cash.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) rose 11.1% to $10.22 after the company reported fourth-quarter sales growth of 166% year-over-year to $20.3 million, beating the consensus of $20.02 million. Separately, the company announced that it has received $12.8 million in orders from its lead silicon carbide test and burn-in customer for multiple FOX-XP&trade; systems, a FOX&trade; high volume production WaferPak Aligner, and a small number of FOX WaferPak full wafer contactors.</li>
<li>Datadog, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ddog#NASDAQ">DDOG</a>) gained 9.8% to $102.07 after Bernstein initiated coverage on the stock with an Outperform rating and a $172 price target.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) climbed 8.5% to $15.35.</li>
<li>Shopify Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shop#NYSE">SHOP</a>) gained 8.4% to $37.24. Shares of technology and software companies traded higher amid a drop in yields.</li>
<li>Evofem Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evfm#NASDAQ">EVFM</a>) rose 7.1% to $0.8649 after dropping 8% on Tuesday.</li>
<li>Ideanomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idex#NASDAQ">IDEX</a>) gained 6% to $0.7528. Ideanomics unit Solectrac recently announced a partnership with Nolan Manufacturing to produce Solectrac&#39;s e25 electric tractors with additional models slated for future production.</li>
<li>Exela Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xela#NASDAQ">XELA</a>) rose 5.7% to $0.14.</li>
<li>Amazon.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) gained 4% to $ 122.91. Jefferies maintained Amazon.com with a Buy and lowered the price target from $163 to $150.</li>
<li>Netflix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nflx#NASDAQ">NFLX</a>) rose 3.8% to $209.02. Netflix posted better-than-expected earnings for its second quarter. The company ended the second quarter with 220.67 million subscribers, down from a reported 221.64 million in the first quarter.</li>
<li>Omnicom Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/omc#NYSE">OMC</a>) rose 3.2% to $69.54 as the company posted stronger-than-expected results for its second quarter on Tuesday.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Vascular Biogenics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vblt#NASDAQ">VBLT</a>) shares dipped 78.5% to $0.4417 after the company announced the data from its Phase 3 OVAL trial of ofra-vec did not meet the primary endpoints of achieving a statistically significant improvement.</li>
<li>JE Cleantech Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jcse#NASDAQ">JCSE</a>) fell 46.7% to $ 6.44.</li>
<li>FaZe Holdings Inc. (NASDAQ: FAZE) fell 28% to $9.38. A SPAC merger announced between FaZe Clan and B. Riley Principal 150 Merger Corp in October has been completed.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) dipped 21.2% to $1.45 after the company announced topline results for its Onward Phase 3 trial for AD04 in patients with Alcohol Use Disorder.</li>
<li>Inozyme Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inzy#NASDAQ">INZY</a>) dropped 18.5% to $4.4399. Inozyme Pharma announced preliminary biomarker, safety, and pharmacokinetic (PK) data from the first three subjects in the Phase 1 portion of its ongoing Phase 1/2 trial of INZ-701 in ABCC6 Deficiency, which presents as pseudoxanthoma elasticum (PXE) in older individuals.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crkn#NASDAQ">CRKN</a>) fell 17.1% to $0.9199 after the company priced its common stock offering of 1.25 million shares at $0.80 per share.</li>
<li>OptimizeRx Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oprx#NASDAQ">OPRX</a>) dipped 13.5% to $25.88. B. Riley Securities maintained OptimizeRx with a Buy and lowered the price target from $71 to $56.</li>
<li>Belite Bio, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blte#NASDAQ">BLTE</a>) fell 12.8% to $38.00. Belite Bio submitted an Investigational New Drug Application to the FDA to support Phase 3 development of LBS-008 for Stargardt Disease (STGD1), a rare genetic eye disease.</li>
<li>Mesa Royalty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtr#NYSE">MTR</a>) dipped 12.2% to $13.04.</li>
<li>Forestar Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/for#NYSE">FOR</a>) declined 11.8% to $13.96 after the company reported worse-than-expected Q3 EPS and sales results and issued FY22 revenue guidance below estimates.</li>
<li>AMTD Digital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hkd#NYSE">HKD</a>) shares fell 11.6% to $22.00. AMTD Digital shares dropped over 10% on Tuesday on continued volatility following the company&#39;s recent IPO.</li>
<li>ITHAX Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mond#NASDAQ">MOND</a>) dipped 11% to $8.12.</li>
<li>Baker Hughes Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bkr#NYSE">BKR</a>) fell 10.6% to $25.24 after the company reported worse-than-expected Q2 EPS and sales results.</li>
<li>Healthcare Services Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) fell 10.5% to $16.61 after the company posted second-quarter FY22 revenue growth of 6.7% year-over-year to $424.9 million, missing the consensus of $426.72 million.</li>
<li>Biophytis S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpts#NASDAQ">BPTS</a>) dropped 8.7% to $0.84.</li>
<li>Helbiz, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlbz#NASDAQ">HLBZ</a>) fell 6.5% to $0.6151. Helbiz recently released the HelmetChecker, a real-time AI helmet verification, for sale to micro-mobility operators.</li>
</ul>

Intraday Update

BPTS

EVFM

GNLN

HLBZ

This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session

Shares of energy companies are trading higher amid a gain in oil prices due to supply concerns after President Biden was unable to secure a commitment from Saudi Arabia for increased output.

AMTX

ARCH

ARLP

BOOM

CHRD

CLMT

CLNE

EXTN

GEVO

GPRE

SLCA

SMHI

Shares of several energy companies are trading higher as oil prices rebound following Wednesday's weakness. Traders continue to weigh the conflicting effects of demand pressures and supply constraints.

Comments

Mesa Royalty

Vendite allo scoperto

Mesa Royalty (NYSE:MTR) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO